Ftse Mib
38.655,09
0,08%
DAX
22.551,43
0,12%
S&P 500
5.954,50
1,59%
NASDAQ
18.847,28
1,63%
Bitcoin
93.142,96
8,26%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Immunic Inc (IMUX) Immunic Inc (IMUX) Notizie

Immunic Inc

IMUX
1,19
0,07 (6,25%)
01 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/2/202512:30PRNUSImmunic Presents Key Vidofludimus Calcium Data at the..
20/2/202513:30EDGAR2Form 8-K - Current report
20/2/202513:30PRNUSImmunic's Oral IMU-856 Demonstrated Dose-Dependent Increase..
14/2/202516:16EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
12/2/202515:44EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
04/2/202512:30PRNUSImmunic to Participate in Investor and Scientific..
13/1/202514:32EDGAR2Form 8-K - Current report
07/1/202512:30PRNUSImmunic Highlights 2024 Accomplishments and Upcoming..
18/12/202422:36EDGAR2Form 8-K - Current report
06/12/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202412:30PRNUSImmunic, Inc. to Participate in Investor Conference in..
14/11/202423:33EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202412:58EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202420:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202412:30PRNUSImmunic Announces Publication of Data From Phase 1/1b..
12/11/202415:31EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
07/11/202413:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202412:45EDGAR2Form 8-K - Current report
07/11/202412:30PRNUSImmunic, Inc. Reports Third Quarter 2024 Financial Results..
31/10/202411:30PRNUSImmunic, Inc. to Announce Financial Results for the Third..
29/10/202411:30PRNUSImmunic to Participate in Industry, Scientific and Investor..
22/10/202412:45EDGAR2Form 8-K - Current report
22/10/202412:30PRNUSImmunic Announces Positive Outcome of Interim Analysis of..
18/9/202412:30PRNUSImmunic Presents Key Vidofludimus Calcium Data at the 40th..
10/9/202422:05EDGAR2Form 8-K - Current report
04/9/202412:30PRNUSImmunic Announces First Patient Enrolled in..
03/9/202414:30EDGAR2Form 8-K - Current report
28/8/202412:30PRNUSImmunic to Host Multiple Sclerosis R&D Day and Participate..
08/8/202413:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202412:45EDGAR2Form 8-K - Current report
08/8/202412:30PRNUSImmunic, Inc. Reports Second Quarter 2024 Financial Results..
01/8/202412:30PRNUSImmunic, Inc. to Announce Financial Results for the Second..
24/7/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/7/202412:40EDGAR2Form 8-K - Current report
24/7/202412:30PRNUSImmunic, Inc. Strengthens Its Board of Directors with the..
12/7/202414:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/7/202412:40EDGAR2Form 8-K - Current report
09/7/202412:30PRNUSImmunic Appoints Jason Tardio as Chief Operating Officer and..
12/6/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/5/202412:30PRNUSImmunic to Participate in Industry and Scientific..
24/5/202422:06EDGAR2Form S-3/A - Registration statement under Securities Act of..
08/5/202413:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202412:45EDGAR2Form 8-K - Current report
Apertura: 1,11 Min: 1,09 Max: 1,19
Chiusura: 1,12

La tua Cronologia

NASDAQ
IMUX
Immunic
BIT
YACHT
Ferretti
BIT
UC1H2B
Unicredit Bank
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci